19 May 2022

TAVI

The conundrum of antithrombotic therapy in atrial fibrillation patients undergoing TAVI

Sponsored by Daiichi Sankyo, Inc.

Anchorperson: R. Moreno

Moderator: N. Van Mieghem

SHOW MORE

Summary

Consult this session to learn more about the characteristics of atrial fibrillation patients undergoing TAVI, the priority of stroke prevention in atrial fibrillation patients post-TAVI, as well as the current understanding in Japanese and Asian patients.

Learning Objectives

To discuss the patient characteristics of atrial fibrillation patients undergoing TAVI
To discuss the priority of stroke prevention in atrial fibrillation patients post-TAVI
To discuss the current understanding in Japanese and Asian patients

Speaker

Session objectives

Download presentation

Speaker

Atrial fibrillation patients undergoing TAVI are the high-risk group among the atrial fibrillation population

Download presentation

N. Van Mieghem

Speaker

Balancing safety and efficacy of NOAC in atrial fibrillation patients post TAVI

Download presentation